FDA approves Madrigal Pharmaceuticals drug as first treatment for common NASH liver disease
In this photo illustration, the Madrigal Pharmaceuticals logo is displayed on a smartphone screen. Rafael Henrique | SOPA Images | Lightrocket ...
Tag: Disease
Novo Nordisk’s Wegovy wins FDA approval for cutting heart disease risks, in move that could expand insurance coverage
Injection pens of Novo Nordisk's weight-loss drug Wegovy are shown in this photo illustration in Oslo, Norway, Nov. 21, 2023.Victoria ...
Menopausal women who get migraines at higher risk for cardiovascular disease, study says
Menopausal women who get migraines could be at higher risk for cardiovascular disease Menopausal women who get migraines could be ...
World leaders are gathering to discuss Disease X. Here’s what to know about the hypothetical pandemic.
World leaders gathered at the World Economic Forum's annual meeting in Davos, Switzerland, on Wednesday to discuss Disease X, a ...
‘Disease X’ could cause the next pandemic, according to the WHO—or Ebola, SARS, or Nipah. 9 pathogens researchers are keeping a watchful eye on
The annual meeting of the World Economic Forum—to be held in Davos, Switzerland, next week—is on more radars than usual ...
The increasing hazard of black lung disease facing coal miners
West Virginia, October. Friday night football. The Oak Hill Red Devils are hosting the Buckhannon Buccaneers. In small town America, ...
FDA approves first gene therapy for sickle cell disease
FDA approves first gene therapy for sickle cell disease - CBS News
FDA approves gene-editing treatment for sickle cell disease
The U.S. Food and Drug Administration on Friday approved a landmark gene-editing treatment for sickle cell disease, a painful condition ...
Michael J. Fox talks funding breakthrough research for Parkinson’s disease
After more than three decades of living with Parkinson's disease, actor Michael J. Fox has raised awareness and over $2 ...
Potential cure for sickle cell disease raises few concerns for FDA panel
A panel of the Food and Drug Administration's outside advisers voiced few concerns Tuesday during a daylong meeting wrestling with ...
